Simple blood test may predict fertility treatment success

NCT ID NCT07415928

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a blood test measuring certain hormones (Inhibin B and FSH) can predict the type of testicular damage in men with a condition called non-obstructive azoospermia, where no sperm are found in the semen. Researchers analyzed data from 73 men who had a surgical sperm retrieval procedure. They found that the ratio of these hormones could help distinguish between different patterns of testicular tissue damage, potentially guiding treatment decisions and avoiding unnecessary surgery in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test that helps doctors predict sperm retrieval success in men with azoospermia, avoiding unnecessary surgery.
What could go wrong
This is a small, single-center observational study. The findings need to be confirmed in larger, more diverse groups before they can be used in routine practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AZOOSPERMIA, NONOBSTRUCTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Elazığ Fethi Sekin City Hospital

    Elâzığ, 23100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.